These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 6307712
1. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone. Holaday JW, Pasternak GW, D'Amato RJ, Ruvio BA, Faden AI. Eur J Pharmacol; 1983 May 06; 89(3-4):293-6. PubMed ID: 6307712 [Abstract] [Full Text] [Related]
2. Multiple opioid receptors: evidence for mu-delta binding site interactions in endotoxic shock. Holaday JW, D'Amato RJ. Life Sci; 1983 May 06; 33 Suppl 1():703-6. PubMed ID: 6319921 [Abstract] [Full Text] [Related]
3. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. Pasternak GW, Childers SR, Snyder SH. J Pharmacol Exp Ther; 1980 Sep 06; 214(3):455-62. PubMed ID: 6105201 [Abstract] [Full Text] [Related]
4. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine. Holaday JW, Pasternak GW, Faden AI. Neurosci Lett; 1983 Jun 16; 37(2):199-204. PubMed ID: 6308526 [Abstract] [Full Text] [Related]
5. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Pasternak GW, Childers SR, Snyder SH. Science; 1980 May 02; 208(4443):514-6. PubMed ID: 6245448 [Abstract] [Full Text] [Related]
7. Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympathomedullary involvement. Holaday JW, D'Amato RJ, Ruvio BA, Feuerstein G, Faden AI. Circ Shock; 1983 Aug 27; 11(3):201-10. PubMed ID: 6317225 [Abstract] [Full Text] [Related]
8. Naloxone in endotoxic shock: experimental models and clinical perspective. Gurll N. Adv Shock Res; 1983 Aug 27; 10():63-71. PubMed ID: 6308974 [Abstract] [Full Text] [Related]
9. Dual effect of morphiceptin on lordosis behavior: possible mediation by different opioid receptor subtypes. Pfaus JG, Pendleton N, Gorzalka BB. Pharmacol Biochem Behav; 1986 May 27; 24(5):1461-4. PubMed ID: 3014568 [Abstract] [Full Text] [Related]
10. Effects of opioid agonists and opioid antagonists in endotoxic shock in rats. Tseng CS, Tso HS. Ma Zui Xue Za Zhi; 1993 Mar 27; 31(1):1-8. PubMed ID: 7968322 [Abstract] [Full Text] [Related]
11. Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites. Hahn EF, Pasternak GW. Life Sci; 1993 Mar 27; 31(12-13):1385-8. PubMed ID: 6292633 [Abstract] [Full Text] [Related]
12. Different receptors mediate morphine-induced prolactin and growth hormone release. Spiegel K, Kourides IA, Pasternak GW. Life Sci; 1993 Mar 27; 31(20-21):2177-80. PubMed ID: 6298516 [Abstract] [Full Text] [Related]
13. Morphine catalepsy in the rat: involvement of mu 1 (high affinity) opioid binding sites. Ling GS, Pasternak GW. Neurosci Lett; 1982 Oct 08; 32(2):193-6. PubMed ID: 6292799 [Abstract] [Full Text] [Related]
14. Multiple opioid receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo. D'Amato R, Holaday JW. Proc Natl Acad Sci U S A; 1984 May 08; 81(9):2898-901. PubMed ID: 6326151 [Abstract] [Full Text] [Related]
15. Naloxazone treatment in the guinea pig ileum in vitro reveals second functional opioid receptor site. James MK, Leighton HJ. J Pharmacol Exp Ther; 1987 Jan 08; 240(1):138-44. PubMed ID: 3027301 [Abstract] [Full Text] [Related]
16. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. Hahn EF, Carroll-Buatti M, Pasternak GW. J Neurosci; 1982 May 08; 2(5):572-6. PubMed ID: 6176696 [Abstract] [Full Text] [Related]
17. Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist. Gahhos FN, Chiu RC, Hinchey EJ, Richards GK. Arch Surg; 1982 Aug 08; 117(8):1053-7. PubMed ID: 6285853 [Abstract] [Full Text] [Related]